| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 03/06/2003 | WO2003017993A1 Photoreactive compounds and compositions |
| 03/06/2003 | WO2003017846A1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy |
| 03/06/2003 | WO2003017824A2 Method and apparatus for acne treatment |
| 03/06/2003 | WO2002055106A3 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 03/06/2003 | WO2001087181A3 Accurate optical treatment of an eye's fundus |
| 03/06/2003 | US20030044393 Method for increasing tumor cell immunogenicity using heat shock protein |
| 03/06/2003 | US20030044390 Applying stresses to blood sampling |
| 03/06/2003 | US20030044354 Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release |
| 03/06/2003 | CA2458476A1 Photoreactive compounds and compositions |
| 03/06/2003 | CA2457590A1 Method and apparatus for acne treatment |
| 03/06/2003 | CA2457589A1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy |
| 03/05/2003 | EP1286996A1 Method and apparatus for inactivation of biological contaminants using photosensitizers |
| 03/05/2003 | EP1286681A1 Irradiation of ispaghula |
| 03/05/2003 | EP0971692B1 Specific magnetosome, method for the production and use thereof |
| 03/05/2003 | EP0724457B1 Radiation sensitization using texaphyrins |
| 03/05/2003 | EP0712293B1 Method of preparing gas-filled lipid microspheres and gas-filled lipid microspheres |
| 03/05/2003 | CN1400906A Treatment of congestive heart failure by pretreated autologous blood |
| 03/04/2003 | US6527759 Ultrasound assembly for use with light activated drugs |
| 02/27/2003 | WO2003015850A1 Method for inducing selectively suppressed immune response |
| 02/27/2003 | WO2003015831A1 Gas microsphere liposome composites |
| 02/27/2003 | WO2003015825A2 Conjugate |
| 02/27/2003 | WO2003015785A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/27/2003 | WO2003015751A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/27/2003 | WO2002096471A3 Viral inactivation process using antioxidant |
| 02/27/2003 | WO2002067850A3 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
| 02/27/2003 | WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 02/27/2003 | US20030040496 Methods for halting unwanted cell growth, such as using ligand-directed nucleic acid delivery vehicles |
| 02/27/2003 | US20030039705 Triterpene compositions and methods for use thereof |
| 02/27/2003 | US20030039613 Novel therapeutic delivery systems |
| 02/27/2003 | CA2456988A1 Gas microsphere liposome composites |
| 02/27/2003 | CA2456985A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/27/2003 | CA2456149A1 Recombinant conjugate polypeptides for photodynamic therapy |
| 02/27/2003 | CA2454671A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/26/2003 | EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 02/26/2003 | EP1128837B1 Medicament for preventing and reversing atherosclerosis in mammals |
| 02/26/2003 | EP1052998A4 Compositions and methods for modulating cytokine release in response to genotoxic agents |
| 02/26/2003 | EP0799055B1 Selective and non-invasive visualization or treatment of vasculature |
| 02/26/2003 | CN1102045C Novel compositions containing lipids and stabilizing agent |
| 02/25/2003 | US6525862 Methods and apparatus for optical imaging |
| 02/25/2003 | US6525224 Fused polyhedron borane dianion |
| 02/25/2003 | US6525073 Prevention or treatment of insomnia with a neurokinin-1 receptor antagonist |
| 02/25/2003 | US6524855 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 02/25/2003 | US6524832 Treating the cells with a therapeutically effective amount of ionizing radiation or alkylating agent as DNA damaging agent; contacting the cells with a protein tyrosine kinase inhibitor such as genistein or herbimycin A |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002067998A3 Devices and methods for the treatment of cancer |
| 02/20/2003 | WO2002026236A9 Tumor cell killing by cell cycle checkpoint abrogation combined with inhibition of the 'classical' mitogen activated protein (map) kinase pathway |
| 02/20/2003 | US20030036697 Hollow microspheres with controlled fragility for medical use |
| 02/20/2003 | US20030036538 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest. |
| 02/20/2003 | US20030035813 Immunological treatment methods and agents |
| 02/19/2003 | EP1283707A1 Polymerizable compositions and methods of use |
| 02/19/2003 | EP0729363B1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
| 02/19/2003 | EP0483304B1 Method of inactivation of viral and bacterial blood contaminants |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/18/2003 | US6521604 Compounds containing boron for energy-filtering transmission electron microscopy and for boron neutron-capture therapy |
| 02/18/2003 | US6520981 Significance of dosimetry in photodynamic therapy of injured arteries |
| 02/13/2003 | WO2003011286A1 Core modified porphyrins |
| 02/13/2003 | WO2003011265A2 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds |
| 02/13/2003 | WO2003011106A2 Internal image antibodies for optical imaging and therapy |
| 02/13/2003 | WO2002081028A3 Cytoprotection by phosphotyrosine |
| 02/13/2003 | WO2002078638A3 Morpholino imaging and therapy |
| 02/13/2003 | WO2002065992A3 A cell therapy method for the treatment of tumors |
| 02/13/2003 | WO2002060482A3 Perylenequinones for use with immunotherapy agents |
| 02/13/2003 | US20030032995 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 02/13/2003 | US20030032950 Cooling system for a photo cosmetic device |
| 02/13/2003 | US20030032943 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 02/13/2003 | US20030032799 For cancer treatment |
| 02/13/2003 | US20030032611 Method to inhibit cell growth using oligonucleotides |
| 02/13/2003 | US20030032610 Administering one or more oligonucleotides which share at least 50% nucleotide sequence identity with (TTAGGG)n or oligonucleotides which share at least 50% nucleotide sequence identity with the human telomere overhang repeat. |
| 02/13/2003 | US20030031738 Saponin mixtures and compounds are isolated from the species Acacia victoriae; e.g., glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents |
| 02/13/2003 | US20030031676 Conjugate compounds for treating atheroma and other diseases |
| 02/13/2003 | US20030031627 For diagnosis and therapy |
| 02/13/2003 | CA2454136A1 5-aminolevulinic acid and esters, in combination with another photosensitizer, as photosensitizing agents in photochemotherapy, and their uses in_treating wounds |
| 02/12/2003 | EP1283047A1 Method for producing a bioactive substance from blood serum |
| 02/11/2003 | US6519076 Methods and apparatus for optical imaging |
| 02/11/2003 | US6518312 Activator protein (AP); treating diseases associated with immune suppressive states; benzmides such as N-((2-Diethylamino)propyl)-4-isobutyrylamino-2-methoxy-benzamide |
| 02/11/2003 | US6517808 Boron neutron capture therapy used to destroy tumors; carboranes encapsulated in liposomes; |
| 02/06/2003 | WO2002066060A3 Method and device for ultrasound-assisted transmembrane medicament application in vitro |
| 02/06/2003 | WO2002062385A3 Method to prevent vision loss |
| 02/06/2003 | WO2002040639A3 Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients |
| 02/06/2003 | WO2002039953A3 Texaphyrin coordination compounds and uses thereof |
| 02/05/2003 | EP1280550A2 Electroporation for introduction of molecules into cells |
| 02/05/2003 | EP0928611B1 Medical powder |
| 02/04/2003 | US6515017 Polyamino acid conjugated paclitaxel or docetaxel have increased water solubility, efficacy and accumulation within a tumor |
| 02/04/2003 | US6514193 Method of administering a therapeutically active substance |
| 01/30/2003 | WO2003008430A2 Porphyrin derivatives for photodynamic therapy |
| 01/30/2003 | WO2003007996A1 Drug delivery systems and treatments using them |
| 01/30/2003 | WO2003007979A1 An anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
| 01/30/2003 | WO2003007944A1 Treatment of macular edema with photodynamic therapy |
| 01/30/2003 | US20030023283 Method and apparatus for the stimulation of hair growth |
| 01/30/2003 | US20030023081 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 01/30/2003 | US20030022275 Human nk-3 related prostate specific gene-1 |
| 01/30/2003 | US20030022105 Two -photon upconverting dyes and applications |
| 01/30/2003 | CA2454357A1 An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration |
| 01/30/2003 | CA2453997A1 Porphyrin derivatives for photodynamic therapy |
| 01/29/2003 | EP1279676A1 Porphyrin derivatives for photodynamic therapy |
| 01/29/2003 | EP1278512A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 01/29/2003 | CN1099869C Photosensibilizers |
| 01/28/2003 | US6511971 Substituted perhalogenated phthalocyanines |
| 01/23/2003 | WO2003006434A1 Metal complexes for use in boron neutron capture therapy |
| 01/23/2003 | WO2003006059A1 Vegfr-1 antibodies to treat breast cancer |